Core Viewpoint - Jinhe Industrial's stock price has shown fluctuations, with a recent increase of 2.04%, but a year-to-date decline of 6.81%, indicating potential volatility in the market [1][2]. Company Overview - Jinhe Industrial, established on December 25, 2006, and listed on July 7, 2011, is located in Chuzhou, Anhui Province. The company specializes in the research, production, and sales of food additives, functional chemical products, and various high-end intermediates, serving sectors such as food and beverage, daily consumer goods, healthcare, agriculture, and advanced manufacturing [1][2]. - The revenue composition of Jinhe Industrial includes: food additives (48.10%), bulk chemicals (37.84%), functional chemical products and intermediates (5.34%), others (4.08%), electricity (3.27%), pharmaceutical intermediates (1.30%), and trade (0.08%) [1]. Financial Performance - For the period from January to September 2025, Jinhe Industrial reported a revenue of 3.543 billion yuan, a year-on-year decrease of 12.35%, and a net profit attributable to shareholders of 391 million yuan, down 4.44% year-on-year [2]. - Since its A-share listing, Jinhe Industrial has distributed a total of 3.017 billion yuan in dividends, with 1.005 billion yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Jinhe Industrial reached 39,000, an increase of 14.63% from the previous period, while the average circulating shares per person decreased by 12.76% to 14,516 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited as the second-largest shareholder with 12.904 million shares, a decrease of 749,600 shares from the previous period. Other notable shareholders include Southern CSI 1000 ETF and Huaxia CSI 1000 ETF, with changes in their holdings [3].

Investment Rating - The investment rating for the company is "Buy" and is maintained [8]. Core Views - The company reported a revenue of 3.54 billion yuan for the first three quarters of 2025, a year-on-year decrease of 12.4%. The net profit attributable to shareholders was 390 million yuan, down 4.4% year-on-year, while the net profit after deducting non-recurring items was 350 million yuan, a decline of 6.5% year-on-year. In Q3 alone, revenue was 1.1 billion yuan, down 26.9% year-on-year and 3.8% quarter-on-quarter. The net profit attributable to shareholders for Q3 was 57 million yuan, a significant drop of 65.0% year-on-year and 38.5% quarter-on-quarter, with the net profit after deducting non-recurring items at 14 million yuan, down 89.1% year-on-year and 87.5% quarter-on-quarter [5][6]. Summary by Sections Financial Performance - For the first three quarters of 2025, the company achieved a total revenue of 3.54 billion yuan, with a year-on-year decline of 12.4%. The net profit attributable to shareholders was 390 million yuan, reflecting a decrease of 4.4% year-on-year. The net profit after deducting non-recurring items was 350 million yuan, down 6.5% year-on-year. In Q3, the company reported revenue of 1.1 billion yuan, a year-on-year decrease of 26.9% and a quarter-on-quarter decrease of 3.8%. The net profit attributable to shareholders for Q3 was 57 million yuan, down 65.0% year-on-year and 38.5% quarter-on-quarter, with the net profit after deducting non-recurring items at 14 million yuan, down 89.1% year-on-year and 87.5% quarter-on-quarter [5][6]. Market Dynamics - The prices of key products such as sucralose and acesulfame have been under pressure, leading to a decline in profit margins. The prices for sucralose, acesulfame, and other related products were reported as 20.2, 3.6, 10.2, and 7.9 thousand yuan per ton, with respective changes of -19.2%, -4.5%, +1.8%, and -2.8% [11]. Future Outlook - The company has made significant progress in key project developments, which are expected to lay a solid foundation for future growth. The second phase of the Dingyuan project has achieved substantial results, including the successful trial production of an 80,000-ton electronic-grade hydrogen peroxide project and the completion of key production facilities for lithium salt precursors [11]. The company anticipates revenue growth in the coming years, with projected earnings of 510 million yuan, 860 million yuan, and 1.07 billion yuan for 2025, 2026, and 2027 respectively [11].

Investment Rating - The report maintains a "Strong Buy" rating for Jinhe Industrial, with a target price of 25.80 CNY [2][8]. Core Insights - Jinhe Industrial's Q3 performance was under pressure, with a revenue of 1.099 billion CNY, down 26.91% year-on-year and 3.76% quarter-on-quarter. The net profit attributable to shareholders was 57 million CNY, a decrease of 64.98% year-on-year and 38.49% quarter-on-quarter [2][4]. - The company is expected to recover as demand returns to normal, particularly in the sweetener market, where prices have reached a low point [8][9]. - The report highlights the company's ongoing development in the semiconductor and synthetic biology sectors, which are anticipated to open new growth opportunities [8][9]. Financial Performance Summary - For the first three quarters of 2025, Jinhe Industrial achieved a total revenue of 3.543 billion CNY, a year-on-year decrease of 12.35%. The net profit attributable to shareholders was 391 million CNY, down 4.44% year-on-year [2][4]. - The report provides financial forecasts for 2024 to 2027, indicating a projected revenue of 4.822 billion CNY in 2025, with a year-on-year decline of 9.1% [4][9]. - The expected net profit for 2025 is revised to 518 million CNY, reflecting a decrease of 6.9% compared to previous estimates [8][9]. Market and Business Analysis - The report notes a significant decline in the average prices of key products such as sucralose and acesulfame, which has impacted profitability. The average price of sucralose in Q3 was 20.20 thousand CNY per ton, down 19.19% [8][9]. - Export volumes for sucralose and acesulfame also saw declines of 20.48% and 13.48% respectively, attributed to overseas inventory reduction efforts [8][9]. - The company is actively pursuing growth in electronic-grade chemicals and synthetic biology, with successful project launches expected to enhance its product offerings [8][9].

FESHING T 2025 年 11 月 04 日 25Q3 需求淡季叠加成本抬升, 业盈利环比走弱,周期有望 -基础化工行业 2025 年三季报总结 证券分析师 马昕晔 A0230511090002 maxy@swsresearch.com 宋涛 A0230516070001 songtao@swsresearch.com 相关研究 25Q3 油煤中枢环比抬升，成本端压力增加，叠加需求淡季，行业盈利环比承压，在建 工程持续回落。25Q3 传统淡季下游开工降低，整体处于去库状态，叠加能源价格底部 ● 反弹，部分周期品价差高位回落，业绩环比承压。国际贸易环境缓和，国内 "反内卷" 政策信号释放，叠加在建工程持续回落，化工供需平衡表边际修复，景气底部迎来长周 期向上。25Q3 Brent 现货均价为 69.29 美元/桶（YoY-14%，QoQ+2%），动力煤市场 用网址。2018年05月17 0020-59797 0020-596)，（1000年5月），4 润 336 亿元（YoY+10%，QoQ-5%），符合市场预期。成本压力叠加需求淡季，化工盈 利能力环比下滑，毛利率同环比分别+0.4、-0.3pct 至 ...

Investment Rating - The report maintains a "Positive" rating for the chemical industry [4][5]. Core Viewpoints - The chemical industry is experiencing a seasonal demand downturn combined with rising costs, leading to a decline in profitability. However, there are signs of a potential recovery as the cycle approaches a bottom [4][6]. - The report highlights that the overall revenue for the chemical sector in Q3 2025 was 543.8 billion yuan, a year-on-year increase of 4% but a quarter-on-quarter decrease of 1%. Net profit reached 33.6 billion yuan, up 10% year-on-year but down 5% quarter-on-quarter [4][29]. - The report emphasizes the importance of focusing on demand-driven sectors such as the textile and agricultural chains, as well as export-related products, while also considering the benefits from the "anti-involution" policies [4][5]. Summary by Sections 1. Chemical Sector Overview - In Q3 2025, the chemical sector faced a traditional seasonal downturn with reduced downstream operations, leading to a state of inventory reduction. The average price of Brent crude oil was $69.29 per barrel, down 14% year-on-year but up 2% quarter-on-quarter. The average price of thermal coal was approximately 673.10 yuan per ton, down 21% year-on-year but up 5% quarter-on-quarter [4][29]. - The overall gross margin for the chemical sector was 17.6%, with a slight year-on-year increase of 0.4% but a quarter-on-quarter decrease of 0.3% [4][29]. 2. Industry Profitability Under Pressure - The report notes that the profitability of the chemical sector is under pressure due to rising costs and seasonal demand declines. The average asset-liability ratio for the sector is 49.6%, remaining stable year-on-year and slightly down by 0.5% quarter-on-quarter [4][29][35]. - Specific segments such as agricultural chemicals are performing well, with net profit growth in areas like fertilizers and pesticides, while other segments like titanium dioxide and organic silicon are experiencing significant declines [4][5]. 3. Investment Opportunities - The report suggests focusing on sectors with high growth potential, such as the textile chain, agricultural chain, and export-related products. Key companies to watch include Lu Xi Chemical, Tongkun Co., and Wan Hua Chemical [4][5][6]. - The report also highlights the importance of key materials and self-sufficiency in the semiconductor and AI+ sectors, recommending companies like Yake Technology and Dinglong Co. for investment [4][5].

Group 1: Chemical Sector Insights - The chemical sector reported a slight increase in profitability in the first three quarters of 2025, with overall revenue up by 2.6% year-on-year and net profit up by 9.4% [6][7] - Notable profit growth was observed in sub-sectors such as pesticides (201%), fluorochemicals (124.6%), adhesives and tapes (91.7%), and potassium fertilizers (62.2%), while significant declines were seen in organic silicon (-73.0%), soda ash (-68.7%), nylon (-52.3%), and titanium dioxide (-46.3%) [6][7] - The report suggests a long-term optimistic outlook for the chemical sector due to supply-side improvements and low inventory levels, while short-term caution is advised due to falling oil prices and potential price declines in chemical products [6] Group 2: Qingdao Beer Company Analysis - Qingdao Beer Company reported a revenue of 29.367 billion yuan for the first three quarters of 2025, reflecting a year-on-year increase of 1.41%, with a net profit of 5.274 billion yuan, up by 5.70% [11][12] - The company experienced a slight decline in Q3 revenue, attributed to a generally weak market demand, with a total sales volume of 6.894 million kiloliters, up by 1.61% year-on-year [12][13] - The company is expected to achieve stable growth for the full year, supported by product structure upgrades and cost reductions, with a projected net profit of 4.653 billion yuan for 2025 [14] Group 3: Zhejiang Dingli Company Overview - Zhejiang Dingli reported a revenue of 6.675 billion yuan for the first three quarters of 2025, an increase of 8.82% year-on-year, with a net profit of 1.595 billion yuan, up by 9.18% [16][17] - The company faced challenges in export sales, with a 13.7% decline in high-altitude work platform exports, which accounted for 61.21% of total sales [19] - The company is focusing on R&D and innovation to maintain its competitive edge, launching new products and exploring electric and digital technologies [18] Group 4: Kaili Medical Company Insights - Kaili Medical achieved a revenue of 1.459 billion yuan in the first three quarters of 2025, a year-on-year increase of 4.37%, but reported a net profit decline of 69.25% [21][22] - The company’s Q3 revenue was 495 million yuan, reflecting a significant year-on-year increase of 28.41%, driven by a recovery in hospital procurement [22][23] - Despite the revenue growth, the company faced pressure on profit margins due to increased costs and competitive pricing in the medical device sector [23] Group 5: Zhuosheng Microelectronics Performance - Zhuosheng Microelectronics reported a revenue of 2.769 billion yuan for the first three quarters of 2025, a decrease of 17.77% year-on-year, with a net loss of 171 million yuan [26][27] - The company’s Q3 revenue showed a slight year-on-year decline of 1.62%, but a quarter-on-quarter increase of 12.36%, indicating a potential recovery trend [28] - The company is focusing on improving production capacity and product mix, particularly in high-end RF modules, to enhance profitability in the upcoming quarters [28][29] Group 6: Non-Bank Financial Sector Performance - The non-bank financial sector saw a 0.5% decline in the index, with significant growth in net profits for listed brokerages, which increased by 62% year-on-year in the first three quarters of 2025 [32][33] - The financial market is expected to remain active, driven by improved brokerage revenues from trading and margin financing activities [33] - Regulatory developments are anticipated to enhance investor protection and market stability, which could positively impact the sector's performance [33] Group 7: North American Cloud Providers and AI Chip Market - North American cloud providers reported a 75% year-on-year increase in capital expenditures in Q3 2025, focusing heavily on AI infrastructure [36][37] - Qualcomm announced its entry into the AI chip market with the launch of AI200 and AI250 chips, aiming to compete with Nvidia in the high-end AI data center segment [38] - The overall electronic industry is experiencing a recovery in demand, with rising prices for storage chips and increased domestic production efforts [36][39] Group 8: Rongchang Bio's Financial Performance - Rongchang Bio achieved a revenue of 1.720 billion yuan in the first three quarters of 2025, a year-on-year increase of 42.27%, while net losses narrowed by 48.60% [41] - The company reported a Q3 revenue of 622 million yuan, reflecting a 33.13% increase year-on-year, indicating strong commercial performance [41] - The improvement in financial performance is attributed to the successful commercialization of core products and effective cost management strategies [41]

Investment Rating - The report rates the industry as "Overweight" [1] Core Viewpoints - The chemical industry is expected to see structural optimization on the supply side, with a focus on selecting resilient and advantageous sectors. Domestic policies frequently emphasize supply-side requirements, while rising raw material costs and capacity shocks in Asia have led to shutdowns and capacity exits among European and American chemical companies. In the short term, geopolitical tensions increase uncertainty in overseas chemical supply, but in the long term, China's chemical industry chain has a clear competitive advantage due to significant cost advantages and continuous technological breakthroughs, which are expected to reshape the global chemical industry landscape [6][15] - The basic chemical sector's profitability showed a slight year-on-year increase in the first three quarters of 2025, with overall revenue up by 2.6% and net profit up by 9.4%. Notable profit growth was seen in pesticides, fluorochemicals, adhesives, and potassium fertilizers, while significant declines were noted in organic silicon, soda ash, nylon, and titanium dioxide [14][15] Summary by Sections Investment Suggestions - Focus on sectors with significant supply elasticity such as organic silicon, membrane materials, chlorine-alkali, and dyes, with key companies including Hoshine Silicon Industry, Xingfa Group, Dongcai Technology, and Zhejiang Longsheng. Additionally, monitor leading companies in sectors with relative advantages, such as Baofeng Energy in coal chemicals and Juhua Co. in fluorochemicals [6][15] Industry Performance - For the week of October 27 to October 31, 2025, the Shanghai and Shenzhen 300 Index fell by 0.43%, while the Shenwan Basic Chemical Index rose by 2.50%, outperforming the market by 2.93%. The top-performing sub-sectors included fluorochemicals and inorganic salts, with increases of 8.40% and 7.68%, respectively [18][19] Price Data Tracking - The top price increases for the week included Vitamin E (up 13.10%), acetone (up 4.88%), and nitric acid (up 3.85%). Conversely, the largest price declines were seen in propylene (down 6.22%) and acrylic acid (down 6.11%) [28][29]

Group 1 - On November 3, Jinhe Industrial executed a block trade of 160,000 shares, with a transaction value of 3.008 million yuan, accounting for 2.23% of the total trading volume for the day [1][2] - The transaction price was 18.80 yuan, which represents a discount of 5.53% compared to the market closing price of 19.90 yuan [1][2]

Investment Rating - Industry Rating: Neutral (maintained rating) [7] Core Views - The chemical raw materials and products manufacturing industry saw a year-on-year investment decline of 5.6% in the first nine months of the year, while industrial investment grew by 6.4% [2][14] - Key price movements include a 6.9% increase in WTI oil prices, with significant price rises in Vitamin E (+11.8%) and sulfur (+11.7%) [3][4] - The basic chemical sector increased by 2.74% over the past week, underperforming the CSI 300 index by 0.5 percentage points [5][17] Summary by Sections 1. Key News Tracking - National Bureau of Statistics reported a total fixed asset investment of 371535 billion yuan, a year-on-year decrease of 0.5% [2][14] - The chemical raw materials and products manufacturing sector's investment fell by 5.6% [2][14] 2. Key Chemical Product Price Monitoring - Among 345 tracked chemical products, 60 saw price increases, while 93 experienced declines [27] - The top five chemical products with price increases include liquid nitrogen (+16.1%), liquid oxygen (+14.3%), and natural gas (+12.8%) [30] 3. Key Individual Stock Tracking - The top-performing stocks in the basic chemical sector include Shilong Industrial (+49.32%) and Nongxin Technology (+27.25%) [22] - The worst-performing stocks include Shanshui Technology (-17.22%) and Chengxing Shares (-14.81%) [24] 4. Sector Valuation - As of October 24, the basic chemical sector's PB ratio is 2.4 times, while the overall A-share market's PB is 1.72 times [25] - The PE ratio for the basic chemical sector stands at 27.86 times compared to the overall A-share market's 17.75 times [25] 5. Focused Sub-industry Insights - Demand stability and global supply dominance are highlighted in sub-industries such as sucralose and pesticides [6] - Recommendations include companies like Jinhai Real Estate and Yunnong Chemical for agricultural chemicals [6]

证券代码：002597 证券简称：金禾实业 公告编号：2025-061 安徽金禾实业股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 安徽金禾实业股份有限公司（以下简称"公司"）于2025年9月11日召开第 七届董事会第三次会议，并于2025年9月29日召开2025年第三次临时股东会，审 议通过了《关于<第三期核心员工持股计划（草案）>及其摘要的议案》《关于< 第三期核心员工持股计划管理办法>的议案》和《关于提请股东会授权董事会办 理第三期核心员工持股计划相关事宜的议案》，同意公司实施第三期核心员工持 股计划，公司第三期核心员工持股计划股票来源为公司回购专用账户回购的公司 股份，本次员工持股计划持有人购买公司回购股份的价格为18元/股，具体内容 详见公司分别于2025年9月12日、2025年9月30日在《证券日报》《证券时报》《上 海证券报》《中国证券报》以及巨潮资讯网（www.cninfo.com.cn）上披露的相 关公告。 根据《关于上市公司实施员工持股计划试点的指导意见》及《深圳证券交易 所上市公司自律监管指引第1号——主板上市公司规范运作》 ...